Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
66
days
Integrative Analysis of Cuproptosis-Related Genes and Repurposable Therapeutic Agents in Type A Aortic Dissection
Authors
Chengbin Tang; Yi Dai; Tao Chen; Jun Shao; Tao Zhu; Jingting Ye; Yusheng ShuShow moreShow less
Affiliations
1. Northern Jiangsu People’s Hospital Affiliated to Yangzhou University, Yangzhou, China; 2. Department of Center for Cardiac Macrovascular Disease, Northern Jiangsu People’s Hospital, Yangzhou, China; 3. Department of Thoracic Surgery, Northern Jiangsu People’s Hospital, Yangzhou, ChinaShow moreShow less
130
days
Salidroside Alleviates Atherosclerosis by Inhibiting Ferroptosis Through the RAG1/Keap1/Nrf2 Axis
Authors
Xiangnan Song; Qing Yang; Jie Yang; Jiali Xu; Yingyu Xiang; Yanhong Liu; Hui ChiShow moreShow less
Affiliations
1. Clinical Laboratory Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, China; 2. Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, Harbin, ChinaShow moreShow less
17
days
Interpreting Antithrombotic Outcomes After Valve-in-Valve TAVI: The Importance of Event Timing and Hemodynamic Trajectories
Authors
Teruhiko ImamuraShow moreShow less
Affiliations
1. Second Department of Internal Medicine, University of Toyama, Toyama, JapanShow moreShow less
37
days
Ivabradine Versus Digitalis Glycosides in Heart Failure With Reduced Ejection Fraction: A Comparative Appraisal of Two Additional Medical Therapies
Authors
Vittorio Beltrani; Marco Bergonti; Martin R. Gruebler; Giordano M. Pugliesi; Luca Fazzini; Mattia Arrigo; Gregorio TersalviShow moreShow less
Affiliations
1. Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland; 2. Department of Cardiology, Istituto Cardiocentro Ticino, Lugano, Switzerland; 3. Department of Internal Medicine, Ente Ospedaliero Cantonale, Mendrisio, Switzerland; 4. Department of Cardiology, University Hospital Wiener Neustadt, Danube Private University, Wiener Neustadt, Austria; 5. Department of Internal Medicine, Medical University of Graz, Graz, Austria; 6. Medical Faculty, Sigmund Freud University, Vienna, Austria; 7. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, USA; 8. Non-Invasive Cardiac Imaging Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy; 9. Cardiovascular Department, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy; 10. Department of Internal Medicine, Ente Ospedaliero Cantonale, Lugano, SwitzerlandShow moreShow less
17
days
Fixed-Dose Combination Versus Add-On Therapy: Clarifying the Role of Cilostazol–Rosuvastatin in Peripheral Artery Disease
Authors
Dezheng Lu; Chunyan KuangShow moreShow less
Affiliations
1. Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, China; 2. Department of Cardiology, Guizhou Provincial People’s Hospital, Guiyang, ChinaShow moreShow less
62
days
Organelle Homeostasis and Metabolic Resilience: TFEB at the Crossroads of Lysosomal and Mitochondrial Adaptation
Authors
Matthew J. Brody; Nageswara R. MadamanchiShow moreShow less
Affiliations
1. Department of Pharmacology, University of Michigan Medical School, Ann Arbor, USA; 2. Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, USAShow moreShow less
FAQ
How long does CARDIOVASCULAR DRUGS AND THERAPY take to review a manuscript?
As of 2026-11-19, CrushSCI has 20 complete review records for CARDIOVASCULAR DRUGS AND THERAPY. The fastest paper went from submission to acceptance in 14 days (Rethinking Plaque Stabilization with Evolocumab in Diabetes: Methodological Considerations from the YELLOW III Trial, received 2026-09-27, accepted 2026-10-11); the slowest took 130 days. The average is 51.0 days and the median is 45.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
